Combined modality therapy improves overall survival for angiosarcoma.

Autor: Shen CJ; a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA., Parzuchowski AS; a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA., Kummerlowe MN; a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA., Morris CD; b Department of Orthopaedic Surgery , Johns Hopkins Hospital , Baltimore , MD , USA., Meyer CF; c Department of Oncology , Johns Hopkins Hospital , Baltimore , MD , USA., Habibi M; d Department of Surgery , Johns Hopkins Hospital , Baltimore , MD , USA., Frassica DA; a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA., Levin AS; b Department of Orthopaedic Surgery , Johns Hopkins Hospital , Baltimore , MD , USA., Thornton KA; c Department of Oncology , Johns Hopkins Hospital , Baltimore , MD , USA.; e Center for Sarcoma and Bone Oncology , Dana-Farber Cancer Institute , Boston , MA , USA., Terezakis SA; a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
Jazyk: angličtina
Zdroj: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2017 Sep; Vol. 56 (9), pp. 1235-1238. Date of Electronic Publication: 2017 Mar 30.
DOI: 10.1080/0284186X.2017.1306104
Databáze: MEDLINE